Search results for “adjuvant”

About 13 results in articles

Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing articles matching adjuvant — open any to read the full text, or download the PDF or XML.

Capsaicin: A Potential Therapy Adjuvant for Intestinal Bowel Disease

Nov 2019 DOI 10.14302/issn.2574-4526.jddd-19-3063
Jacqueline I Alvarez-LeiteCorresponding author

Most of the patients with inflammatory bowel disease avoid pepper or spicy food, alleging that this condiment causes anal sensation of burning and accelerates intestinal movements. Capsaicin is the main bioactive component of peppers responsible for the pungent flavor that characterizes red peppers.…

Metabolic Correction Therapy as Adjuvant Treatment for Breast Cancer Patients: A Case Report

Jan 2018
Michael J GonzalezCorresponding author

Breast cancer is the most common cancer in women worldwide. In the United States, is the second leading cause of cancer deaths in women. In Puerto Rico between 2008 and 2012, breast cancer was the most diagnosed type of cancer and the leading cause of cancer deaths among women. This is a case of 54…

Regulation of Expression of Reactive Oxygen Intermediates During Plasmodium Infection to Reduce Immunopathology Provides a Possible Antioxidant Adjuvant to Enhance Anti-Malarial Drug Therapy

Aug 2017 DOI 10.14302/issn.2690-4721.ijcm-17-1676
Andrew W. Taylor-RobinsonCorresponding author

Malaria is a mosquito-transmitted infectious disease caused by intracellular protozoan parasites of the genus Plasmodium. In the absence of prompt and appropriate treatment contraction of primary infection by a human being often represents a medical emergency since it may progress rapidly to life-th…

Development of Poly-ε-Caprolactone Based Nanoadjuvant for Effective Vaccination Against Tuberculosis

Apr 2014 DOI 10.14302/issn.2377-2549.jndc-13-329
Amit Kumar DindaCorresponding author

The aim of the study was to synthesize sub-100nm poly-ε-caprolactone nanoparticles (PCL NP), load them with the mycobacterial protein, ESAT 6 and study the resulting immune responses in CD4+ and CD8+ T cells when incubated with human peripheral blood monocyte derived macrophages that had internalize…

Conjunctival Resection for Mooren's Ulcer Refractory to Medical Therapy: A Case Report

Jan 2026 DOI 10.14302/issn.2470-0436.jos-25-5905
Mohammed Al-YarabiCorresponding author

Purpose To report a rare case of Mooren’s ulcer in a healthy young male without systemic autoimmune disease, and to highlight the effectiveness of conjunctival resection as therapy for cases unresponsive to medical management. Case report A 34-year-old immunocompetent male presented with progressive…

Retrospective Evaluation of Well Differentiated Thyroid Cancer Treatment Outcomes: 50 year experience at the University of Puerto Rico

Dec 2025 DOI 10.14302/issn.2574-4496.jtc-25-5497
Frieda SilvaCorresponding author

Our study gathered information on the diagnosis, treatment, and long-term outcome in adult and pediatric Hispanic patients with Well Differentiated Thyroid Cancer. Methods We performed a retrospective review of the clinical and imaging nuclear medicine records of cases of WDTC evaluated and treated…

Radio-Induced Maxillary Angiosarcoma: About a Case

May 2025 DOI 10.14302/issn.2379-8572.joa-25-5504
Mohamed HachemiCorresponding author

Introduction Angiosarcoma is a rare malignant tumour from fast-evolving and aggressive vascular endothelial cells that accounts for 1% of all sarcomas. The sinus location of angiosarcoma is exceptional. The clinical polymorphism of this tumour may cause a delay in diagnosis. Risk factors are not alw…

Primary Breast Sarcoma

Oct 2022 DOI 10.14302/issn.2641-5518.jcci-22-4323
Gracieux Y. FernandoCorresponding author

Introduction Primary sarcomas of the breast are <0.1% of all malignant tumours of the breast. To date, there are 13 major breast sarcoma series in English literature. This study adds to these series characterizing primary breast sarcoma among Philippine patients. Methods All breast biopsies from the…

Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)

Oct 2019 DOI 10.14302/issn.2641-7669.ject-19-3040
Abdul Kader MohiuddinCorresponding author

Many lay people along with some so called “key opinion leaders” have a common slogan “There's no answer for cancer”. Again, mistake delays proper treatment and make situation worse, more often. Compliance is crucial to obtain optimal health outcomes, such as cure or improvement in QoL. Patients may…

Squamous Cell Carcinoma of the Conjunctiva (Scc) and Human Immunodefisciency Virus (Hiv): What Reality in Ivory Coast Through 23 Cases?

Sep 2017 DOI 10.14302/issn.2324-7339.jcrhap-17-1694
R Berete CoulibalyCorresponding author

Introduction: Squamous cell carcinomas of the conjunctiva (SCC) are rare neoplasia but have a high rate of increase and a high rate of mortality, especially when they occur in the context of Human Immunodeficiency Virus (HIV) infection. The objective of this study was to establish an epidemiological…

Management of Locally Advanced and Metastatic Pediatric Nasopharyngeal Carcinoma. Experience of Children Cancer Hospital – Egypt

Oct 2015 DOI 10.14302/issn.2379-8572.joa-15-691
Hany Abdel RahmanCorresponding author

Background. Nasopharyngeal carcinoma (NPC) is a rare disease in the pediatric age group; it represents 1% of all pediatrics malignancies, however, it is the predominant malignancy arising in the nasopharynx in this age group. Although NPC is a chemo-radiosensitive disease yet, the optimal dose of ra…

Leiomyosarcoma of the Thyroid Gland: A Review of the Literature and our Experience

May 2015 DOI 10.14302/issn.2574-4496.jtc-13-347
Emilio MevioCorresponding author

Primary thyroid leiomyosarcoma, is extremely rare, with only 19 cases reported in the literature to date. Onset of the tumor, which usually develops in only one lobe of the thyroid, is sudden and the tumor spreads rapidly to surrounding tissues. Preoperative differential diagnosis is extremely diffi…

Frequently asked questions

Are these articles peer-reviewed?
Yes. Articles published at Open Access Pub go through single-blind peer review (double-blind on request) under an editorial board before publication.
Are the articles free to read?
Yes. Every article is open access — read the full text online for free and download the PDF or XML, with no paywall or subscription.
How do I cite an article?
Use the DOI shown on each result and on the article page; it is the permanent, citable link to the article.
How do I read or download an article?
Click "Read full text" to open the article HTML, or use the PDF / XML buttons on each card to download it.